{"id":80084,"date":"2015-10-26T04:39:25","date_gmt":"2015-10-26T08:39:25","guid":{"rendered":"http:\/\/countingpips.com\/?p=80084"},"modified":"2015-10-26T05:45:39","modified_gmt":"2015-10-26T09:45:39","slug":"valeant-woes-prove-dangers-of-reaching-for-yield","status":"publish","type":"post","link":"https:\/\/www.investmacro.com\/forex\/2015\/10\/valeant-woes-prove-dangers-of-reaching-for-yield\/","title":{"rendered":"Valeant Woes Prove Dangers of \u201cReaching for Yield\u201d"},"content":{"rendered":"<div id=\"inves-3945415629\" class=\"inves-below-title-posts inves-entity-placement\"><div id =\"posts_date_custom\"><div align=\"left\">October 26, 2015<\/div><hr style=\"border: none; border-bottom: 3px solid black;\">\r\n<\/div><\/div><p>By <a href=\"http:\/\/WallStreetDaily.com\/\"><u>WallStreetDaily.com<\/u><\/a> <img loading=\"lazy\" decoding=\"async\" class=\"attachment-home-th wp-post-image\" style=\"display: block; margin-bottom: 5px; clear: both;\" src=\"http:\/\/www.wallstreetdaily.com\/wp-content\/uploads\/2015\/10\/10-26-valeant-pharmaceuticals-high-yield-bonds.jpg\" alt=\"Valeant Pharmaceuticals Proves Danger of Chasing High-Yield\" width=\"510\" height=\"300\" \/><\/p>\n<p>By <a href=\"http:\/\/www.wallstreetdaily.com\/author\/alan-gula\/\">Alan Gula<\/a><em>, Chief Income Analyst <\/em><\/p>\n<p>When we look back on this period in the financial markets, how will it be remembered?<\/p>\n<p>Well, I believe that the last couple of years will largely be defined by the \u201creach for yield\u201d and exuberance in the high-yield bond market.<\/p>\n<p>It\u2019s become common to dismiss the problems in high-yield land because they\u2019re seemingly limited to the energy sector. However, the market is slowly going to realize that the high-yield debacle isn\u2019t \u201ccontained.\u201d<\/p>\n<p>And last week, the junk bond market got a jolt.<\/p><div id=\"inves-4138530103\" class=\"inves-in-content inves-entity-placement\"><hr style=\"border: 1px solid #ddd;\">\r\n<div id=\"inpost_ads_header\">\r\n<p style=\"font-size:10px; float:left; color:#666;\">Free Reports:<\/p><\/div>\r\n<div id=\"inpost_ads\"> \r\n<p style=\"font-size:15px; float:left;\"><a href=\"https:\/\/goo.gl\/1ApBOV\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/investmacro.com\/wp-content\/uploads\/2018\/06\/graph_techs_PD.png\" align=\"left\" width=\"80\"  height=\"55\"\/><\/a>\r\n\t     <a href=\"https:\/\/goo.gl\/1ApBOV\"><b><u>Get Our Free Metatrader 4 Indicators<\/u><\/b><\/a> - Put Our Free MetaTrader 4 Custom Indicators on your charts when you join our Weekly Newsletter<\/p><br><br>\r\n<br>\r\n<br>\r\n<p style=\"font-size:15px; float:left;\"><a href=\"https:\/\/goo.gl\/f3RrHX\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/investmacro.com\/wp-content\/uploads\/2019\/01\/cot_pie_80.png\" align=\"left\" width=\"80\"  height=\"55\"\/><\/a>\r\n\t    <a href=\"https:\/\/goo.gl\/f3RrHX\"><b><u>Get our Weekly Commitment of Traders Reports<\/u><\/b><\/a> - See where the biggest traders (Hedge Funds and Commercial Hedgers) are positioned in the futures markets on a weekly basis.<\/p><br><br>\r\n<\/div>\r\n<hr style=\"border: 1px solid #ddd;\">\r\n<br><\/div>\n<h2>A Nasty Shock for Yield-Chasing Valeant Investors<\/h2>\n<p>As you probably know, shares of <strong><a href=\"http:\/\/www.wallstreetdaily.com\/2015\/02\/24\/salix-valeant-pharmaceuticals\/\">Valeant Pharmaceuticals\u00a0International Inc<\/a>.\u00a0<\/strong>(<a href=\"http:\/\/finance.yahoo.com\/q?s=VRX&amp;ql=0\" target=\"_blank\">VRX<\/a>) got hammered last week when the company became the target of fraud allegations.<\/p>\n<p>As for the company\u2019s fixed-income offerings\u2026 the 6.125% bonds due in 2025 traded down to $83.50 on October 22. As recently as early August, those same bonds traded for more than $104.<\/p>\n<p>The following table shows some of the largest U.S. high-yield issuers this year. Valeant actually tops the list.<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"aligncenter\" src=\"http:\/\/media.wallstreetdaily.com\/charts\/1015_Top2015.png\" alt=\"Top 2015 U.S. High-Yield Bond Issuers\" width=\"500\" height=\"655\" \/><\/p>\n<p>It probably comes as a surprise to many Valeant equity traders and investors that the company has a sub-investment grade credit rating.<\/p>\n<p>Now, Valeant may or may not default. But what\u2019s clear is that the mispricing in the high-yield debt market allows companies like Valeant to lever up with impunity.<\/p>\n<p>Equity shareholders are also complicit for having failed to punish companies with too much leverage.<\/p>\n<p>Whether it\u2019s a sharp decline in oil prices, corporate malfeasance, an economic downturn, or some other unforeseen event, the risks that may cause a default are manifold.<\/p>\n<p>And these risks pose an even greater threat to investors in highly-levered companies.<\/p>\n<p>Nonetheless, investors are flooding back into junk bonds.<\/p>\n<h2>Like Lambs to the Slaughter<\/h2>\n<p>So far in October, the <strong>SPDR Barclays High Yield Bond ETF<\/strong> (<a href=\"http:\/\/finance.yahoo.com\/q?s=jnk&amp;ql=1\" target=\"_blank\">JNK<\/a>) and the <strong>iShares iBoxx High Yield Corporate Bond ETF<\/strong> (<a href=\"http:\/\/finance.yahoo.com\/q?s=hyg&amp;ql=1\" target=\"_blank\">HYG<\/a>) have experienced inflows of $2.1 billion and $1.7 billion, respectively.<\/p>\n<p>According to Lipper, high-yield funds saw their largest weekly inflow since October 2011 this month.<\/p>\n<p>As you can tell, the herd mentality driving the reach for yield lives on. Like lambs to the slaughter\u2026<\/p>\n<p>The energy sector was simply the first to get hit, but now the credit cycle has turned. In other words, credit availability is starting to dry up.<\/p>\n<p>Before it\u2019s all said and done, <em>every<\/em> sector\u2019s high yield bonds will be a disaster. At that point, most high-yield bonds will actually be <em>high<\/em> yielding because the default rate will be shocking.<\/p>\n<p>It will also be a time to load up on this risky segment of the fixed-income universe.<\/p>\n<p>Unfortunately, that opportunity is still some way off yet.<\/p>\n<p>Safe (and high-yield) investing,<\/p>\n<p>Alan Gula, CFA<\/p>\n<p>The post <a href=\"http:\/\/www.wallstreetdaily.com\/2015\/10\/26\/valeant-pharmaceuticals-high-yield-bonds\/\" rel=\"nofollow\">Valeant Woes Prove Dangers of \u201cReaching for Yield\u201d<\/a> appeared first on <a href=\"http:\/\/www.wallstreetdaily.com\" rel=\"nofollow\">Wall Street Daily<\/a>.<\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>By WallStreetDaily.com By Alan Gula, Chief Income Analyst When we look back on this period in the financial markets, how will it be remembered? Well, I believe that the last couple of years will largely be defined by the \u201creach for yield\u201d and exuberance in the high-yield bond market. It\u2019s become common to dismiss the [&hellip;]<\/p>\n","protected":false},"author":3,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-80084","post","type-post","status-publish","format-standard","hentry","no-post-thumbnail"],"_links":{"self":[{"href":"https:\/\/www.investmacro.com\/forex\/wp-json\/wp\/v2\/posts\/80084","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.investmacro.com\/forex\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.investmacro.com\/forex\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.investmacro.com\/forex\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.investmacro.com\/forex\/wp-json\/wp\/v2\/comments?post=80084"}],"version-history":[{"count":2,"href":"https:\/\/www.investmacro.com\/forex\/wp-json\/wp\/v2\/posts\/80084\/revisions"}],"predecessor-version":[{"id":80094,"href":"https:\/\/www.investmacro.com\/forex\/wp-json\/wp\/v2\/posts\/80084\/revisions\/80094"}],"wp:attachment":[{"href":"https:\/\/www.investmacro.com\/forex\/wp-json\/wp\/v2\/media?parent=80084"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.investmacro.com\/forex\/wp-json\/wp\/v2\/categories?post=80084"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.investmacro.com\/forex\/wp-json\/wp\/v2\/tags?post=80084"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}